Company: CODI-PB
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001140361-25-013771
Chunk: 15

Company: Compass Diversified Holdings
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 15
---
 (Chair) and Audit         |
| Heidi Locke Simon       
 Independent Director    |     |  57 |     |                                 2023 |     | Audit                                  |
| Nancy B. Mahon          
 Independent Director    |     |  60 |     |                                 2023 |     | Nominating/Governance (Chair)          |
| Teri R. Shaffer         
 Independent Director    |     |  63 |     |                                 2022 |     | Audit (Chair)                          |
| Elias J. Sabo(3)        
 Director and Officer    |     |  54 |     |                                 2018 |     | Chief Executive Officer                |
| Stephen Keller          
 Officer                 |     |  50 |     |                                 2024 |     | Chief Financial Officer                |

| (1) | Mr. Bottiglieri is not standing for re-election at the 2025 Annual Meeting. |

| (2) | Mr. Burns is not standing for re-election at the 2025 Annual Meeting. |

| (3) | Mr. Sabo, the Allocation Member’s appointed director, is not standing for election at the 2025 Annual Meeting. |

TABLE OF CONTENTS

| 18 |     | 2025 Proxy |

Our Chief Financial Officer The following describes the experience, education and other qualifications of our current Chief Financial Officer.

| Stephen Kellerhas served as Chief Financial Officer of the Company and Executive Vice President of the Company’s Manager since August 31, 2024. He also serves on the Investment Committee of the Company’s Manager, the organization’s Sustainability Committee, and the Company’s Enterprise Risk Management Committee. He is an observer to the boards of directors of all our subsidiary companies. Prior to joining us in 2024, Mr. Keller served as interim chief financial officer and vice president of investor relations at Envista Holdings Corporation (NYSE: NVST), a $2.6 billion company and one of the leading suppliers of dental solutions globally. During his time at Envista, he also served as vice president strategy and business development, as well as vice president and general manager of Nobel Biocare’s Prosthetics Business Unit. Prior to Envista, Mr. Keller worked at Avery Dennison Corporation (NYSE: AVY), an $8 billion global materials science company. At Avery Dennison, he held various positions of increasing responsibility in finance, strategy, and general management, including vice president, strategy and corporate development, vice president of finance for Asia